Health Care: Drugs

Valeant Pharmaceuticals International Inc (VRX: NYSE)

$12.83 n/a | n/a%
05/26/17 - 04:02 PM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 9.67B 10.45B 8.21B 5.77B
Cost of Sales 2.30B 2.23B 1.98B 1.70B
Gross Operating Profit 7.37B 8.22B 6.23B 4.07B
Selling, General, and Administrative Expenses 2.81B 2.70B 2.03B 1.31B
Research & Development 421.00M 334.00M 246.00M 156.80M
Operating Income before D & A (EBITDA) 4.14B 5.18B 3.96B 2.61B
Depreciation & Amortization 2.98B 2.61B 1.68B 2.11B
Interest Income 8.00M 4.00M 5.00M 8.00M
Other Income - Net -30.00M -322.00M 0.00 -75.80M
Special Income / Charges -1.64B -589.00M 111.00M -440.80M
Total Income Before Interest Expenses (EBIT) -599.00M 1.41B 2.02B -470.10M
Interest Expense 1.84B 1.56B 971.00M 844.30M
Pre-Tax Income -2.44B -155.00M 1.05B -1.31B
Income Taxes -27.00M 133.00M 174.00M -450.80M
Minority Interest 1.00M 4.00M -1.00M 2.50M
Net Income From Continuing Operations -2.41B -288.00M 880.00M -863.60M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -2.41B -288.00M 880.00M -863.60M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -2.41B -292.00M 881.00M -866.10M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-672.00M 557.00M 1.13B 39.20M
Preferred Dividends
Net Income Available To Common -2.41B -288.00M 880.00M -863.60M
Basic EPS from Continuing Ops. -6.94 -0.85 2.63 -2.70
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -6.94 -0.85 2.63 -2.70
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -6.94 -0.85 2.63 -2.70
Basic Normalized Net Income/Share -1.94 1.64 3.38 0.12
EPS fr Continuing Ops. -6.94 -0.85 2.58 -2.70
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -6.94 -0.85 2.58 -2.70
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -6.94 -0.85 2.58 -2.70
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-1.94 1.64 3.32 0.12
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with VRX

Latest VRX Headlines from TheStreet

More Financial News for VRX

Press Releases for VRX

See All Press Releases
brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter